TA86: Gastro-intestinal stromal tumours (GIST) - imatinib
This is a discussion on TA86: Gastro-intestinal stromal tumours (GIST) - imatinib within the Updates from the Technology Assessment Authorities forum, part of the Industry News and Updates category; The summary for the published technology appraisal on Gastro-intestinal stromal tumours (GIST) - imatinib. It links to the published guidance ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
04-01-2010, 12:51 PM
|
|||
|
|||
TA86: Gastro-intestinal stromal tumours (GIST) - imatinib
The summary for the published technology appraisal on Gastro-intestinal stromal tumours (GIST) - imatinib. It links to the published guidance and key documents.
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| TA70: Leukaemia (chronic myeloid) - imatinib | industry_news | Updates from the Technology Assessment Authorities | 0 | 04-01-2010 12:51 PM |
| TA179: Gastrointestinal stromal tumours - sunitinib | industry_news | Updates from the Technology Assessment Authorities | 0 | 04-01-2010 12:51 PM |
| TA179: Gastrointestinal stromal tumours - sunitinib | industry_news | Updates from the Technology Assessment Authorities | 0 | 09-22-2009 08:06 PM |
| Targeted Therapies Improve Outcomes in Renal Cancer and GIST, but Challenges Remain | industry_news | Other Clinical Pharmacy News | 0 | 09-14-2008 08:19 AM |
| One Third of CML Patients Need Alternative to Imatinib | industry_news | Other Clinical Pharmacy News | 0 | 07-17-2008 02:59 PM |
© 2008 DrugManagementForum™ powered by |
 |